188 related articles for article (PubMed ID: 28864019)
21. Elevated Glucose and Insulin Levels Decrease DHA Transfer across Human Trophoblasts via SIRT1-Dependent Mechanism.
Mishra JS; Zhao H; Hattis S; Kumar S
Nutrients; 2020 Apr; 12(5):. PubMed ID: 32365792
[TBL] [Abstract][Full Text] [Related]
22. Placental glucose transporter (GLUT)-1 is down-regulated in preeclampsia.
Lüscher BP; Marini C; Joerger-Messerli MS; Huang X; Hediger MA; Albrecht C; Baumann MU; Surbek DV
Placenta; 2017 Jul; 55():94-99. PubMed ID: 28623979
[TBL] [Abstract][Full Text] [Related]
23. Alterations in placental long chain polyunsaturated fatty acid metabolism in human intrauterine growth restriction.
Chassen SS; Ferchaud-Roucher V; Gupta MB; Jansson T; Powell TL
Clin Sci (Lond); 2018 Mar; 132(5):595-607. PubMed ID: 29463583
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of placental folate transporters in intrauterine growth restriction.
Chen YY; Gupta MB; Grattton R; Powell TL; Jansson T
J Nutr Biochem; 2018 Sep; 59():136-141. PubMed ID: 29986308
[TBL] [Abstract][Full Text] [Related]
25. Protein expression of fatty acid transporter 2 is polarized to the trophoblast basal plasma membrane and increased in placentas from overweight/obese women.
Lager S; Ramirez VI; Gaccioli F; Jang B; Jansson T; Powell TL
Placenta; 2016 Apr; 40():60-6. PubMed ID: 27016784
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis.
Liang HL; Ma SJ; Xiao YN; Tan HZ
Medicine (Baltimore); 2017 Sep; 96(38):e7939. PubMed ID: 28930827
[TBL] [Abstract][Full Text] [Related]
27. Maternal BMI and gestational diabetes alter placental lipid transporters and fatty acid composition.
Segura MT; Demmelmair H; Krauss-Etschmann S; Nathan P; Dehmel S; Padilla MC; Rueda R; Koletzko B; Campoy C
Placenta; 2017 Sep; 57():144-151. PubMed ID: 28864004
[TBL] [Abstract][Full Text] [Related]
28. Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes.
Prieto-Sánchez MT; Ruiz-Palacios M; Blanco-Carnero JE; Pagan A; Hellmuth C; Uhl O; Peissner W; Ruiz-Alcaraz AJ; Parrilla JJ; Koletzko B; Larqué E
Clin Nutr; 2017 Apr; 36(2):513-521. PubMed ID: 26869380
[TBL] [Abstract][Full Text] [Related]
29. Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes.
Camelo Castillo W; Boggess K; Stürmer T; Brookhart MA; Benjamin DK; Jonsson Funk M
JAMA Pediatr; 2015 May; 169(5):452-8. PubMed ID: 25822253
[TBL] [Abstract][Full Text] [Related]
30. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review.
Nicholson W; Bolen S; Witkop CT; Neale D; Wilson L; Bass E
Obstet Gynecol; 2009 Jan; 113(1):193-205. PubMed ID: 19104375
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of the LAT1 in primary human trophoblast cells increases the uptake of essential amino acids and activates mTOR signaling.
Rosario FJ; Urschitz J; Powell TL; Brown TL; Jansson T
Clin Sci (Lond); 2023 Nov; 137(21):1651-1664. PubMed ID: 37861075
[TBL] [Abstract][Full Text] [Related]
32. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia.
Ramos GA; Jacobson GF; Kirby RS; Ching JY; Field DR
J Perinatol; 2007 May; 27(5):262-7. PubMed ID: 17363911
[TBL] [Abstract][Full Text] [Related]
33. Differential levels of amino acid transporters System L and ASCT2, and the mTOR protein in placenta of preeclampsia and IUGR.
Aiko Y; Askew DJ; Aramaki S; Myoga M; Tomonaga C; Hachisuga T; Suga R; Kawamoto T; Tsuji M; Shibata E
BMC Pregnancy Childbirth; 2014 May; 14():181. PubMed ID: 24886642
[TBL] [Abstract][Full Text] [Related]
34. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
Jacobson GF; Ramos GA; Ching JY; Kirby RS; Ferrara A; Field DR
Am J Obstet Gynecol; 2005 Jul; 193(1):118-24. PubMed ID: 16021069
[TBL] [Abstract][Full Text] [Related]
35. Metformin compared with glyburide for the management of gestational diabetes.
Silva JC; Pacheco C; Bizato J; de Souza BV; Ribeiro TE; Bertini AM
Int J Gynaecol Obstet; 2010 Oct; 111(1):37-40. PubMed ID: 20542272
[TBL] [Abstract][Full Text] [Related]
36. Insulin Treatment May Alter Fatty Acid Carriers in Placentas from Gestational Diabetes Subjects.
Ruiz-Palacios M; Prieto-Sánchez MT; Ruiz-Alcaraz AJ; Blanco-Carnero JE; Sanchez-Campillo M; Parrilla JJ; Larqué E
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587267
[TBL] [Abstract][Full Text] [Related]
37. Maternal glucagon-like peptide-1 is positively associated with fetal growth in pregnancies complicated with obesity.
Dumolt JH; Rosario FJ; Kramer AC; Horwitz S; Powell TL; Jansson T
Clin Sci (Lond); 2023 Apr; 137(8):663-678. PubMed ID: 37014924
[TBL] [Abstract][Full Text] [Related]
38. Effects of chronic hypoxia in vivo on the expression of human placental glucose transporters.
Zamudio S; Baumann MU; Illsley NP
Placenta; 2006 Jan; 27(1):49-55. PubMed ID: 16310037
[TBL] [Abstract][Full Text] [Related]
39. Activity and protein expression of the Na+/H+ exchanger is reduced in syncytiotrophoblast microvillous plasma membranes isolated from preterm intrauterine growth restriction pregnancies.
Johansson M; Glazier JD; Sibley CP; Jansson T; Powell TL
J Clin Endocrinol Metab; 2002 Dec; 87(12):5686-94. PubMed ID: 12466372
[TBL] [Abstract][Full Text] [Related]
40. Increased ubiquitination and reduced plasma membrane trafficking of placental amino acid transporter SNAT-2 in human IUGR.
Chen YY; Rosario FJ; Shehab MA; Powell TL; Gupta MB; Jansson T
Clin Sci (Lond); 2015 Dec; 129(12):1131-41. PubMed ID: 26374858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
